Emphysema

May 3, 2016May 4, 2016

FDA Approves COPD Treatment Bevespi Aerosphere, a Long-acting Dual Bronchodilator

Chronic Bronchitis, COPD, Emphysema, News

The U.S. FDA has approval AstraZeneca’s Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) for long-term maintenance treatment of airflow obstruction in patients suffering from chronic obstructive pulmonary disease (COPD), including emphysema and/or chronic bronchitis. ... Read more

April 28, 2016May 31, 2016

Scientists Discover Shared Genes in COPD and IPF, Pointing to Potential Drug Development

COPD, Emphysema, Idiopathic Pulmonary Fibrosis, News

Despite sharing some risk factors, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are usually studied in isolation, and the presence of possible shared molecular mechanisms has been unknown. Now, in a new study ... Read more

April 11, 2016April 11, 2016

Segmental Vapor Ablation for Emphysema Improves Patients’ Pulmonary Function, Researchers Find

Emphysema, News

In a new study, researchers investigated whether selective treatment with vapor ablation of the more diseased lobe segments in the lungs led to clinical improvements in patients suffering from severe ... Read more

March 31, 2016May 13, 2016

Stiolto Respimat for COPD Granted FDA’s Supplemental NDA Approval

Chronic Bronchitis, COPD, Emphysema, News

The FDA has approved a supplemental New Drug Application (sNDA) for Boehringer Ingelheim’s Stiolto Respimat, which, according to the company, adds data to the product’s label demonstrating improvements in health and quality ... Read more

March 21, 2016March 21, 2016

Experts Recommend Zephyr EBV as Only Minimally Invasive Emphysema Treatment for Use Outside Clinical Trials

Emphysema, News

Pulmonx, based in Redwood City, California, recently announced the publication of recommendations from a panel of experts offering broad guidance regarding selection of therapies for patients with advanced emphysema. The panel recommended that only ... Read more

March 1, 2016March 1, 2016

Lung Disease Patients Need to Work Simple Exercises into Daily Routines, Study Advises

Asthma, Chronic Bronchitis, COPD, Emphysema, News

People with lung disease are advised to do short workouts throughout the day so as to maximize their capacity for physical activity, according to a recent review of studies on ... Read more

February 15, 2016May 13, 2016

Air Pollution Can Lead to Life-Threatening Lung Disease 30 Years Later, Study Finds

Chronic Bronchitis, Emphysema, News, Pneumonia

Exposure to air pollution more than 30 years ago can impact an individual’s current risk of dying of respiratory disease, according to a report from the MRC-PHE Center for Environment and Health, Imperial College ... Read more

February 2, 2016February 3, 2016

FDA Approves IND Application for Multidrug-Resistant Bacterial Infections

Bronchiectasis, COPD, Cystic Fibrosis, Emphysema, News, Pneumonia

Matinas BioPharma Holdings recently announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application, and the company can now begin a Phase 1 clinical trial to ... Read more

January 15, 2016January 15, 2016

Lung Treatment for Severe Emphysema Shown to Improve Exercise Capacity, Study Says

Emphysema, News

According to a study recently issued in the journal JAMA, implanting coils in the lungs can improve exercise aptitude at six months in patients with severe emphysema — a critical component of chronic ... Read more

December 14, 2015December 14, 2015

Advanced Emphysema Patients Respond Well to EBV Therapy in Study

Emphysema, News

Results from the STELVIO trial involving a combination of Zephyr EBV therapy with the Chartis System diagnostic tool revealed significant improvements for patients with severe emphysema. The results were published ... Read more